Deepak jotwani - Latest News Update, Information, Photos & Videos on Deepak jotwani at Lokmat Times

New Delhi, Jan 4 India's pharma sector is expected to grow at 9-11 per cent in FY22, rating agency ICRA said on Tuesday.It attributed the growth to the improving demand for non-Covid products in addition to new product introductions, rupee depreciation, and expanding market coverage."Going forward, sustenance of trend in doctor visits and elective surgeries given the news around the Omicron variant, and performance of new launches in addition to revenue growth momentum in the acute segment will remain key monitorables," ICRA said.Further, pricing pressures and rising raw material costs are expected to contract margins for the sector to 22.5 per cent in FY22 and further to pre-Covid levels of 21-22 per cent in FY23, said Deepak Jotwani, Assistant Vice President and Sector Head, ICRA.The outlook for the pharma sector remains 'Stable' led by healthy revenue growth and is seen remaining comfortable despite higher capital expenditure and R&D expenses given the robust cash levels.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Narendra Modi

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Deepak JotwaniFOLLOW

Deepak jotwani, Latest News

Technology :Growth for Indian IT services industry likely to slow down: ICRA

New Delhi, Feb 6 The growth momentum for the Indian IT services industry is likely to slow down ... ...

Health :Indian pharma sector expected to grow 9-11% in FY22: ICRA

New Delhi, Jan 4 India's pharma sector is expected to grow at 9-11 per cent in FY22, rating ... ...